Related references
Note: Only part of the references are listed.Communicating uncertainties when disclosing diagnostic test results for (Alzheimer's) dementia in the memory clinic: The ABIDE project
Leonie N. C. Visser et al.
HEALTH EXPECTATIONS (2020)
The process of disclosing a diagnosis of dementia and mild cognitive impairment: A national survey of specialist physicians in Denmark
T. Rune Nielsen et al.
DEMENTIA-INTERNATIONAL JOURNAL OF SOCIAL RESEARCH AND PRACTICE (2020)
Factors for predicting reversion from mild cognitive impairment to normal cognition: A meta-analysis
HuiPing Xue et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2019)
Use of mild cognitive impairment and prodromal AD/MCI due to AD in clinical care: a European survey
Daniela Bertens et al.
ALZHEIMERS RESEARCH & THERAPY (2019)
Declining incidence of dementia: A national registry-based study over 20 years
Laerke Taudorf et al.
ALZHEIMERS & DEMENTIA (2019)
The psychological impact of disclosing amyloid status to Japanese elderly: a preliminary study on asymptomatic patients with subjective cognitive decline
Taisei Wake et al.
INTERNATIONAL PSYCHOGERIATRICS (2018)
Estimation of lifetime risks of Alzheimer's disease dementia using biomarkers for preclinical disease
Ron Brookmeyer et al.
ALZHEIMERS & DEMENTIA (2018)
Review of the Ethical Issues of a Biomarker-Based Diagnoses in the Early Stage of Alzheimer's Disease
Gwendolien Vanderschaeghe et al.
JOURNAL OF BIOETHICAL INQUIRY (2018)
Prevalence of amyloid-beta pathology in distinct variants of primary progressive aphasia
David Bergeron et al.
ANNALS OF NEUROLOGY (2018)
Ethical Arguments Concerning the Use of Alzheimer's Disease Biomarkers in Individuals with No or Mild Cognitive Impairment: A Systematic Review and Framework for Discussion
Marthe Smedinga et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Risk Factors of Rapid Cognitive Decline in Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review and Meta-Analysis
Ya-Nan Song et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Communicating mild cognitive impairment diagnoses with and without amyloid imaging
Joshua D. Grill et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment
Sanna-Kaisa Herukka et al.
ALZHEIMERS & DEMENTIA (2017)
Reversion From Mild Cognitive Impairment to Normal Cognition A Meta-Analysis
Michael Malek-Ahmadi
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2016)
Disclosure of positron emission tomography amyloid imaging results: A preliminary study of safety and tolerability
Yen Ying Lim et al.
ALZHEIMERS & DEMENTIA (2016)
Timely Diagnosis for Alzheimer's Disease: A Literature Review on Benefits and Challenges
Bruno Dubois et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
The use of biomarkers for the etiologic diagnosis of MCI in Europe: An EADC survey
Martina Bocchetta et al.
ALZHEIMERS & DEMENTIA (2015)
Prevalence and prognosis of Alzheimer's disease at the mild cognitive impairment stage
Stephanie J. B. Vos et al.
BRAIN (2015)
Prevalence of Cerebral Amyloid Pathology in Persons Without Dementia A Meta-analysis
Willemijn J. Jansen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Critical Comparison of Different Biomarkers for Alzheimer's Disease in a Clinical Setting
David Weise et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Public health guidance to facilitate timely diagnosis of dementia: ALzheimer's COoperative Valuation in Europe recommendations
Dawn Brooker et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2014)
Disclosing a dementia diagnosis: what do patients and family consider important?
Maree Mastwyk et al.
INTERNATIONAL PSYCHOGERIATRICS (2014)
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Bruno Dubois et al.
LANCET NEUROLOGY (2014)
Disclosure of amyloid imaging results to research participants: Has the time come?
Jennifer H. Lingler et al.
ALZHEIMERS & DEMENTIA (2013)
International Work Group Criteria for the Diagnosis of Alzheimer Disease
Jeffrey L. Cummings et al.
MEDICAL CLINICS OF NORTH AMERICA (2013)
Disclosure of Alzheimer's disease biomarker status in subjects with mild cognitive impairment
Pieter Jelle Visser et al.
BIOMARKERS IN MEDICINE (2012)
Dementia knowledge and attitudes of the general public in Northern Ireland: an analysis of national survey data
Patricia McParland et al.
INTERNATIONAL PSYCHOGERIATRICS (2012)
Knowing is Better: Preferences of Diverse Older Adults for Discussing Prognosis
Cyrus Ahalt et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2012)
The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Marilyn S. Albert et al.
ALZHEIMERS & DEMENTIA (2011)
Mild cognitive impairment in clinical care A survey of American Academy of Neurology members
J. S. Roberts et al.
NEUROLOGY (2010)
Mild Cognitive Impairment Ten Years Later
Ronald C. Petersen et al.
ARCHIVES OF NEUROLOGY (2009)
A survey of attitudes of clinicians towards the diagnosis and treatment of mild cognitive impairment in Australia and New Zealand
Terry Mitchell et al.
INTERNATIONAL PSYCHOGERIATRICS (2008)
Ten-year risk of dementia in subjects with mild cognitive impairment
Pieter Jelle Visser et al.
NEUROLOGY (2006)
Mild cognitive impairment -: beyond controversies, towards a consensus:: report of the International Working Group on Mild Cognitive Impairment
B Winblad et al.
JOURNAL OF INTERNAL MEDICINE (2004)
Attitudes of patients with mild dementia and their carers towards disclosure of the diagnosis
G Pinner et al.
INTERNATIONAL PSYCHOGERIATRICS (2003)